Medpace Holdings, Inc. (MEDP) stock
MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$653.09+4.89 (+0.75%)
Close on Nov 17, 2026Market cap $18.27BP/E 36.2Yield –
Medpace profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Medpace's profit margin for the twelve months ending Sep 30, 2026 was 18.2%. For fiscal 2025 it was 17.8%, against 19.2% the year before. The highest annual figure on record is 19.2% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17.8% | −1.3 |
| FY2024 | Dec 31, 2024 | 19.2% | +4.2 |
| FY2023 | Dec 31, 2023 | 15.0% | −1.8 |
| FY2022 | Dec 31, 2022 | 16.8% | +0.9 |
| FY2021 | Dec 31, 2021 | 15.9% | +0.2 |
| FY2020 | Dec 31, 2020 | 15.7% | +4.0 |
| FY2019 | Dec 31, 2019 | 11.7% | +1.3 |
| FY2018 | Dec 31, 2018 | 10.4% | +1.4 |
| FY2017 | Dec 31, 2017 | 9.0% | +5.8 |
| FY2016 | Dec 31, 2016 | 3.2% | +5.6 |
| FY2015 | Dec 31, 2015 | -2.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 19.2% | +2.4 |
| Q2 FY2026 | Jun 30, 2026 | 17.2% | +2.2 |
| Q1 FY2026 | Mar 31, 2026 | 17.5% | −3.0 |
| Q4 FY2025 | Dec 31, 2025 | 19.1% | −2.7 |
| Q3 FY2025 | Sep 30, 2025 | 16.8% | −1.2 |
| Q2 FY2025 | Jun 30, 2025 | 15.0% | −1.8 |
| Q1 FY2025 | Mar 31, 2025 | 20.5% | +0.4 |
| Q4 FY2024 | Dec 31, 2024 | 21.8% | +6.1 |
| Q3 FY2024 | Sep 30, 2024 | 18.1% | +3.8 |
| Q2 FY2024 | Jun 30, 2024 | 16.7% | +3.5 |
| Q1 FY2024 | Mar 31, 2024 | 20.1% | +3.3 |
| Q4 FY2023 | Dec 31, 2023 | 15.7% | −1.7 |
| Q3 FY2023 | Sep 30, 2023 | 14.3% | −2.9 |
| Q2 FY2023 | Jun 30, 2023 | 13.3% | −0.8 |
| Q1 FY2023 | Mar 31, 2023 | 16.8% | −1.7 |
| Q4 FY2022 | Dec 31, 2022 | 17.4% | +1.2 |
| Q3 FY2022 | Sep 30, 2022 | 17.2% | +0.8 |
| Q2 FY2022 | Jun 30, 2022 | 14.1% | −0.3 |
| Q1 FY2022 | Mar 31, 2022 | 18.5% | +1.9 |
| Q4 FY2021 | Dec 31, 2021 | 16.2% | −3.4 |
| Q3 FY2021 | Sep 30, 2021 | 16.4% | −1.6 |
| Q2 FY2021 | Jun 30, 2021 | 14.3% | +2.6 |
| Q1 FY2021 | Mar 31, 2021 | 16.7% | +4.1 |
| Q4 FY2020 | Dec 31, 2020 | 19.6% | +6.6 |
| Q3 FY2020 | Sep 30, 2020 | 18.0% | +6.9 |
| Q2 FY2020 | Jun 30, 2020 | 11.8% | −1.1 |
| Q1 FY2020 | Mar 31, 2020 | 12.5% | +3.0 |
| Q4 FY2019 | Dec 31, 2019 | 13.0% | +1.1 |
| Q3 FY2019 | Sep 30, 2019 | 11.1% | +0.3 |
| Q2 FY2019 | Jun 30, 2019 | 12.8% | +3.1 |
| Q1 FY2019 | Mar 31, 2019 | 9.6% | +0.6 |
| Q4 FY2018 | Dec 31, 2018 | 11.8% | +1.8 |
| Q3 FY2018 | Sep 30, 2018 | 10.8% | +1.9 |
| Q2 FY2018 | Jun 30, 2018 | 9.7% | +0.7 |
| Q1 FY2018 | Mar 31, 2018 | 8.9% | +1.0 |
| Q4 FY2017 | Dec 31, 2017 | 10.0% | +10.0 |
| Q3 FY2017 | Sep 30, 2017 | 8.9% | – |
| Q2 FY2017 | Jun 30, 2017 | 9.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 7.9% | – |
| Q4 FY2016 | Dec 31, 2016 | -0.0% | – |
See a number that looks wrong?